Pancreatic Cancer Research

ResearcherAnhui Medical UniversityNo recent work listed

Zhi‐Gang Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7589-9319; OpenAlex author ID A5101928746. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers

Papers 3

  1. Upregulation of B3GNT3 Correlates With Poor Prognosis and Decreased Immune Cell Infiltration In Pancreatic Adenocarcinoma Last author DOI 10.21203/rs.3.rs-218028/v1↗
  2. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway. Last author DOI 10.3892/ol.2021.12588↗
  3. High-Level Expression and Prognostic Significance of Matrix Metalloprotease-19 and Matrix Metalloprotease-20 in Human Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000000569↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lulu Zhai · 3 shared papers, 2016–2021 · strength 0.34
  2. Lichao Yao · 2 shared papers, 2021 · strength 0.27
  3. Lun Wu · 2 shared papers, 2021 · strength 0.27
  4. Weibo Li · 1 shared paper, 2021 · strength 0.14
  5. Longjiang Chen · 1 shared paper, 2021 · strength 0.14
  6. Lin Ye · 1 shared paper, 2021 · strength 0.13
  7. Chong-Yang Cai · 1 shared paper, 2016 · strength 0.08
  8. Yang Feng Wu · 1 shared paper, 2016 · strength 0.08
  9. Qiang Huang · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.